surmount 5 tirzepatide surmount-1 weight loss nondiabetic non-diabetic obesity trial For the first time, and semaglutide were put in the same trial. SURMOUNT-5. Phase 3b RCT. 751 adults Tirzepatide after intensive lifestyle intervention – Tirzepatide proves to be more

Kidney diseases can lead to a range of complications, including kidney failure, anemia, and nerve damage (neuropathy)

PlexusDx helps you honestly assess readiness and may recommend continuing medication if your foundation isn't solid enough yet

A GLP-1 such as Wegovy or Zepbound can be a reasonable option, but being in perimenopause and already on an antidepressant or other psychiatric medication changes what we check before starting and what we monitor afterward

Indigenous Services Canada coverage varies by region and specific health transfer agreements

They take menopause symptoms into account and personalize medications accordingly